Isoliquiritigenin protects against sepsis-induced lung and liver injury by reducing inflammatory responses
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 496 (2) , 245-252
Abstract
No abstract availableKeywords
Funding Information
- Public Welfare Science and Technology Program of Wenzhou City (Y20130238)
- Natural Science Funding of Zhejiang Province (LY13H150006)
This publication has 32 references indexed in Scilit:
- Anti-Inflammatory Pyranochalcone Derivative Attenuates LPS-Induced Acute Kidney Injury via Inhibiting TLR4/NF-κB PathwayMolecules, 2017
- Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathwayEuropean Journal of Pharmacology, 2016
- Albumin Replacement in Patients with Severe Sepsis or Septic ShockNew England Journal of Medicine, 2014
- The acute respiratory distress syndromeCurrent Opinion in Critical Care, 2014
- Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007Critical Care Medicine, 2012
- Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-Inflammatory AgentsJournal of Medicinal Chemistry, 2011
- Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Incidence and Outcomes of Acute Lung InjuryNew England Journal of Medicine, 2006
- Lipopolysaccharide EndotoxinsAnnual Review of Biochemistry, 2002
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999